Search the Newsreel

Nuveen Churchill Direct Lending (NYSE:NCDL) Upgraded at Wall Street Zen

Nuvectis Pharma (NVCT) Short Interest & Short Float | Updated Jul 2026

As of July 15, 2026, Nuvectis Pharma (NVCT) reported a short interest of 1.51 million shares, representing 7.98% of its public float, marking a 16.12% decrease from the previous report. The short interest ratio is 4.0 days to cover, indicating it would take four …

Nuveen Churchill Direct Lending Corp. Revenue Breakdown – NYSE:NCDL

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) generated $207.86 million USD in revenue last year, primarily from its Investment and Related Activities segment, which accounted for $201.84 million USD. The United States was the company's largest regional contributor, also bringing in $201.84 million USD. …

H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $39

H.C. Wainwright has reiterated its Buy rating on Nuvectis Pharma (NVCT.US) and maintained a target price of $39. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

Nuveen Churchill Direct Lending Corp (NCDL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Nuveen Churchill Direct Lending Corp (NCDL), highlighting its current valuation score of 7.80, which ranks 62nd in its industry. It details the company's P/E ratio of 10.17, noting its position relative to recent highs and lows. The …

(NCDL) Risk Channels and Responsive Allocation

This article analyzes Nuveen Churchill Direct Lending Corp. (NASDAQ: NCDL), highlighting a weak near-term sentiment and a mid-channel oscillation pattern. It identifies an exceptional 23.0:1 risk-reward short setup and provides institutional trading strategies including position, momentum breakout, and risk hedging strategies. The analysis also …

Nuveen Multi-Asset Income Fund (NMAI) Holds Steady as Yield-Seekers Circle - Moving Average Ribbon

Five Stocks to Buy Today: Nuvama Wealth, Samvardhana Motherson, Manappuram Finance, And More | July 24

Nuveen Churchill Direct Lending (NYSE:NCDL) Upgraded by Zacks Research to "Hold" Rating

Zacks Research has upgraded Nuveen Churchill Direct Lending (NCDL) from "strong sell" to "hold" despite the stock trending near its 52-week low. The company recently missed quarterly EPS and revenue estimates, however, insider buying activity by Treasurer Shaul Vichness and CAO Marissa Hassen indicates …

Correction: Nuvectis Announces Marketing Approval of Ciprocopan in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Nuvectis Pharma, Inc. announced that its partner Haisco has received marketing approval in China for ciprocopan (NXP100), a once-daily oral Complement Factor B inhibitor, to treat patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) previously untreated with complement inhibitors. This marks the world's first approval for …

Nuvectis Drug Reached 12 g/dL in 59.5% of PNH Patients

Nuvectis Pharma announced that its once-daily oral Complement Factor B inhibitor, ciprocopan (NXP100), has received marketing approval in China for treating Paroxysmal Nocturnal Hemoglobinuria (PNH) patients previously untreated with complement inhibitors. This marks the first global approval for such a drug and is based …

Ciprocopan (NXP100) Receives Marketing Approval in China

Nuvectis Pharma, Inc. announced that its drug ciprocopan (NXP100), a once-daily oral complement Factor B inhibitor, has received marketing approval in China for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) untrained with complement inhibitors. This approval marks the world's first for such a drug, providing …

Nouveau Monde Graphite Inc. (NMG) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Nouveau Monde Graphite Inc. (NMG), including its current stock price, recent news, historical data, and financial performance. It details the company's operations in graphite exploration and development in Quebec, Canada, and offers analyst insights and …

What's Going On With Nouveau Monde Graphite Inc Stock Wednesday?

Nuveen Churchill Direct Lending Corp. (NYSE:NCDL) Given Consensus Recommendation of "Reduce" by Analysts

Nuveen Churchill Direct Lending Corp. (NYSE:NCDL) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $14.44. The company recently reported mixed quarterly results, missing EPS expectations by a small margin but significantly missing revenue estimates. Despite these results, …

Stocks in Focus Today, 21 July, 2026: Fluorochemicals, Nuvoco Vistas, Prestige Estates Drive Gains in Cement, Chemicals, Realty Pack

Nuvation Bio (NUVB) Corporate presentation Summary

Nuvation Bio (NUVB) presented a corporate summary highlighting its focus on oncology medicines and strong financial position. The company emphasized the success of IBTROZI (taletrectinib), approved for advanced ROS1+ NSCLC, noting its high efficacy, favorable safety profile, and significant market potential. The presentation also …

Liquidity Mapping Around (NPCT) Price Events

The article provides an AI-generated analysis of Nuveen Core Plus Impact Fund (NPCT), highlighting a neutral sentiment and a mid-channel oscillation pattern. It outlines three institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels, and details multi-timeframe signal …

(NMAI) Movement Within Algorithmic Entry Frameworks

This article analyzes Nuveen Multi-asset Income Fund Of Beneficial Interest (NMAI) using AI models, identifying neutral near and mid-term readings but a positive long-term bias. It outlines three distinct trading strategies for NMAI—Position, Momentum Breakout, and Risk Hedging—along with their respective entry, target, and …

Clinuvel Pharmaceuticals (ASX:CUV) Shares Closed Higher Today- What Are Healthcare Investors Watching?

Nuvoco Q1 FY27 net profit rises 20% to ₹160 crore

Cement manufacturer Nuvoco Vistas Corp lays bricks for ₹13K cr FY27 revenue

Nouveau Monde Graphite Inc. (NYSE:NMG) Given Average Recommendation of "Buy" by Brokerages

Seven brokerages have issued a consensus recommendation of "Buy" for Nouveau Monde Graphite Inc. (NYSE:NMG), with an average 12-month price target of $4.67. The stock is currently trading near its 52-week low of $1.37, despite recently beating quarterly earnings expectations. Analysts anticipate the company …

Nuveen Churchill Direct Lending Corp. (NYSE:NCDL) Short Interest Update

Nuveen Churchill Direct Lending Corp. sets Q2 2026 earnings date

Nuveen Churchill Direct Lending Corp. announced it will release its Q2 2026 financial results on August 6, 2026, before market open. The company will host an earnings conference call and webcast at 10:00 AM ET on the same day to discuss the results. Nuveen …

Nuveen Churchill Direct Lending Corp. Schedules Second Quarter 2026 Earnings Release and Conference Call

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) announced it will report its second quarter 2026 financial results on Thursday, August 6, 2026, before market open. The company will host an earnings conference call and webcast at 10:00 AM ET on the same day to …

If EPS Growth Is Important To You, Nuvoco Vistas (NSE:NUVOCO) Presents An Opportunity

Nuveen Churchill to Report Q2 Results Before Markets Open

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) announced it will report its second-quarter 2026 financial results on Thursday, August 6, 2026, before the market opens. The company will also host an earnings conference call and webcast at 10:00 AM ET on the same day …

Nuveen Multi-Asset Income Fund (NMAI) Gains Ground as Yield-Seeking Investors Return - Wave Equality

Clinuvel Pharmaceuticals Moves as Its Global Rare-Disease Opportunity Attracts Fresh Attention

Clinuvel Pharmaceuticals (ASX:CUV) Slips as Biotech Investors Watch Valuation Risk

Vesuvius CFO Increases Stake Through Dividend Reinvestment Plan

Nuveen Churchill adds $100M to its 6.65% debt due 2030

Shanghai Iluvatar CoreX Semiconductor plans $800M share sale in Hong Kong

Clinuvel Pharmaceuticals (ASX:CUV): Nearly 7 years on from the FDA's approval of Scenesse, this company is now at a crossroads

Is Clinuvel Pharmaceuticals (ASX: CUV) Ready for a Bigger Breakout?